TNDM - CIK 0001438133
The table below shows TANDEM DIABETES CARE INC's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $179.32M | $91.95M | $64.11M | $53.57M | $49.04M | $47.70M |
| Short-term investments | $390.93M | $227.16M | $251.25M | $315.05M | $424.27M | $404.72M |
| Receivables | $140.67M | $125.94M | $128.44M | $126.56M | $107.19M | $98.12M |
| Inventory | $126.40M | $137.28M | $142.57M | $141.16M | $152.44M | $161.66M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $887.10M |
| $616.94M |
| $614.82M |
| $663.43M |
| $752.83M |
| $733.39M |
| Property, plant & equipment | $83.25M | $77.92M | $77.51M | $79.22M | $81.06M | $78.63M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.15B | $874.65M | $875.74M | $922.14M | $957.73M | $937.50M |
| Accounts payable | $59.86M | $47.48M | $55.84M | $59.80M | $48.75M | $47.78M |
| Total current liabilities | $247.96M | $252.54M | $251.69M | $288.18M | $259.28M | $240.61M |
| Long-term debt | $601.77M | $309.59M | $309.15M | $308.70M | $307.83M | $307.39M |
| Total liabilities | $1.02B | $741.69M | $742.45M | $766.85M | $720.02M | $703.63M |
| Retained earnings | -$1.27B | -$1.25B | -$1.23B | -$1.18B | -$1.05B | -$1.03B |
| Total equity | $132.40M | $132.97M | $133.28M | $155.29M | $237.71M | $233.88M |